Chen et al. reported that tumor cells could develop drug resistance against PD-1/PD-L1 blocking antibodies by upregulating CD38, which is induced by all-trans retinoic acid and IFN-β in the TME [204]. The gene discussed is CD274; the disease is neoplasm.